Characterization of patients with diabetes who were incidentally found to be glutamic acid decarboxylase autoantibody‐positive by bridging‐type enzyme‐linked immunosorbent assay
Abstract This study aimed to characterize diabetic patients incidentally found to be positive for glutamic acid decarboxylase autoantibodies (GADA) in general practice. Using bridging‐type enzyme‐linked immunosorbent assay, we screened 1,040 patients with phenotypic type 2 diabetes for GADA, finding...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-11-01
|
Series: | Journal of Diabetes Investigation |
Subjects: | |
Online Access: | https://doi.org/10.1111/jdi.13307 |
id |
doaj-cda2fb21e4d24c82a6dcb44c219f78bb |
---|---|
record_format |
Article |
spelling |
doaj-cda2fb21e4d24c82a6dcb44c219f78bb2021-05-02T21:48:54ZengWileyJournal of Diabetes Investigation2040-11162040-11242020-11-011161507151010.1111/jdi.13307Characterization of patients with diabetes who were incidentally found to be glutamic acid decarboxylase autoantibody‐positive by bridging‐type enzyme‐linked immunosorbent assayEiji Kawasaki0Takahiro Fukuyama1Aira Uchida2Yoko Sagara3Hidekazu Tamai4Yuko Nakano5Masayuki Tojikubo6Yuji Hiromatsu7Nobuhiko Koga8Department of Diabetes and Endocrinology Shin‐Koga Hospital Kurume JapanDepartment of Diabetes and Endocrinology Shin‐Koga Hospital Kurume JapanDepartment of Diabetes and Endocrinology Shin‐Koga Hospital Kurume JapanDepartment of Diabetes and Endocrinology Shin‐Koga Hospital Kurume JapanDepartment of Diabetes and Endocrinology Shin‐Koga Hospital Kurume JapanDepartment of Diabetes and Endocrinology Shin‐Koga Hospital Kurume JapanDepartment of Diabetes and Endocrinology Shin‐Koga Hospital Kurume JapanDepartment of Diabetes and Endocrinology Shin‐Koga Hospital Kurume JapanDepartment of Diabetes and Endocrinology Shin‐Koga Hospital Kurume JapanAbstract This study aimed to characterize diabetic patients incidentally found to be positive for glutamic acid decarboxylase autoantibodies (GADA) in general practice. Using bridging‐type enzyme‐linked immunosorbent assay, we screened 1,040 patients with phenotypic type 2 diabetes for GADA, finding 25 (2.4%) to be positive. However, on retesting, with a median interval of 19 days, 44% of GADA‐positive patients turned negative (Disappearing Group). The mean age at diabetes onset was significantly higher (P < 0.05) and GADA titers at first determination were significantly lower (P < 0.001) in the Disappearing Group compared with the Persistent Positive Group. On initial screening, all patients in the Disappearing Group had GADA titers of <6.5 U/mL. The current study showed that a portion of phenotypic type 2 diabetic patients incidentally identified as GADA‐positive were falsely positive, and that to avoid the misclassification, remeasurement of GADA is essential in cases showing very low titers.https://doi.org/10.1111/jdi.13307AutoantibodyFalse positiveSlowly‐progressive type 1 diabetes |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Eiji Kawasaki Takahiro Fukuyama Aira Uchida Yoko Sagara Hidekazu Tamai Yuko Nakano Masayuki Tojikubo Yuji Hiromatsu Nobuhiko Koga |
spellingShingle |
Eiji Kawasaki Takahiro Fukuyama Aira Uchida Yoko Sagara Hidekazu Tamai Yuko Nakano Masayuki Tojikubo Yuji Hiromatsu Nobuhiko Koga Characterization of patients with diabetes who were incidentally found to be glutamic acid decarboxylase autoantibody‐positive by bridging‐type enzyme‐linked immunosorbent assay Journal of Diabetes Investigation Autoantibody False positive Slowly‐progressive type 1 diabetes |
author_facet |
Eiji Kawasaki Takahiro Fukuyama Aira Uchida Yoko Sagara Hidekazu Tamai Yuko Nakano Masayuki Tojikubo Yuji Hiromatsu Nobuhiko Koga |
author_sort |
Eiji Kawasaki |
title |
Characterization of patients with diabetes who were incidentally found to be glutamic acid decarboxylase autoantibody‐positive by bridging‐type enzyme‐linked immunosorbent assay |
title_short |
Characterization of patients with diabetes who were incidentally found to be glutamic acid decarboxylase autoantibody‐positive by bridging‐type enzyme‐linked immunosorbent assay |
title_full |
Characterization of patients with diabetes who were incidentally found to be glutamic acid decarboxylase autoantibody‐positive by bridging‐type enzyme‐linked immunosorbent assay |
title_fullStr |
Characterization of patients with diabetes who were incidentally found to be glutamic acid decarboxylase autoantibody‐positive by bridging‐type enzyme‐linked immunosorbent assay |
title_full_unstemmed |
Characterization of patients with diabetes who were incidentally found to be glutamic acid decarboxylase autoantibody‐positive by bridging‐type enzyme‐linked immunosorbent assay |
title_sort |
characterization of patients with diabetes who were incidentally found to be glutamic acid decarboxylase autoantibody‐positive by bridging‐type enzyme‐linked immunosorbent assay |
publisher |
Wiley |
series |
Journal of Diabetes Investigation |
issn |
2040-1116 2040-1124 |
publishDate |
2020-11-01 |
description |
Abstract This study aimed to characterize diabetic patients incidentally found to be positive for glutamic acid decarboxylase autoantibodies (GADA) in general practice. Using bridging‐type enzyme‐linked immunosorbent assay, we screened 1,040 patients with phenotypic type 2 diabetes for GADA, finding 25 (2.4%) to be positive. However, on retesting, with a median interval of 19 days, 44% of GADA‐positive patients turned negative (Disappearing Group). The mean age at diabetes onset was significantly higher (P < 0.05) and GADA titers at first determination were significantly lower (P < 0.001) in the Disappearing Group compared with the Persistent Positive Group. On initial screening, all patients in the Disappearing Group had GADA titers of <6.5 U/mL. The current study showed that a portion of phenotypic type 2 diabetic patients incidentally identified as GADA‐positive were falsely positive, and that to avoid the misclassification, remeasurement of GADA is essential in cases showing very low titers. |
topic |
Autoantibody False positive Slowly‐progressive type 1 diabetes |
url |
https://doi.org/10.1111/jdi.13307 |
work_keys_str_mv |
AT eijikawasaki characterizationofpatientswithdiabeteswhowereincidentallyfoundtobeglutamicaciddecarboxylaseautoantibodypositivebybridgingtypeenzymelinkedimmunosorbentassay AT takahirofukuyama characterizationofpatientswithdiabeteswhowereincidentallyfoundtobeglutamicaciddecarboxylaseautoantibodypositivebybridgingtypeenzymelinkedimmunosorbentassay AT airauchida characterizationofpatientswithdiabeteswhowereincidentallyfoundtobeglutamicaciddecarboxylaseautoantibodypositivebybridgingtypeenzymelinkedimmunosorbentassay AT yokosagara characterizationofpatientswithdiabeteswhowereincidentallyfoundtobeglutamicaciddecarboxylaseautoantibodypositivebybridgingtypeenzymelinkedimmunosorbentassay AT hidekazutamai characterizationofpatientswithdiabeteswhowereincidentallyfoundtobeglutamicaciddecarboxylaseautoantibodypositivebybridgingtypeenzymelinkedimmunosorbentassay AT yukonakano characterizationofpatientswithdiabeteswhowereincidentallyfoundtobeglutamicaciddecarboxylaseautoantibodypositivebybridgingtypeenzymelinkedimmunosorbentassay AT masayukitojikubo characterizationofpatientswithdiabeteswhowereincidentallyfoundtobeglutamicaciddecarboxylaseautoantibodypositivebybridgingtypeenzymelinkedimmunosorbentassay AT yujihiromatsu characterizationofpatientswithdiabeteswhowereincidentallyfoundtobeglutamicaciddecarboxylaseautoantibodypositivebybridgingtypeenzymelinkedimmunosorbentassay AT nobuhikokoga characterizationofpatientswithdiabeteswhowereincidentallyfoundtobeglutamicaciddecarboxylaseautoantibodypositivebybridgingtypeenzymelinkedimmunosorbentassay |
_version_ |
1721487141284872192 |